2015
DOI: 10.1038/srep18341
|View full text |Cite
|
Sign up to set email alerts
|

Development of a mono-promoter-driven CRISPR/Cas9 system in mammalian cells

Abstract: The CRISPR/Cas9 system has been used for spatio-temporal gene modification through the ubiquitous expression of gRNA by an RNA polymerase III promoter and the controlled expression of Cas9 using a tissue-specific or inducible promoter. However, unexpected gene disruptions indicate the necessity of a tissue-specific or inducible expression of not only Cas9 but also gRNA. In the present study, we attempted to develop a CRISPR/Cas9 system that could express functional gRNAs and Cas9 by a single RNA polymerase II … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
60
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(61 citation statements)
references
References 27 publications
(44 reference statements)
1
60
0
Order By: Relevance
“…This strategy can be combined with single-vector systems validated to express multiple gRNAs driven by polymerase-III promoters (Sakuma et al, 2014; Tsai et al, 2014), which may be useful to increase the effectiveness and flexibility of the gRNAs. Another noteworthy variation is to express gRNAs using polymerase-II promoters, a system that has proven highly efficient and adjustable for inducible expression (Nissim et al, 2014; Yoshioka et al, 2015). …”
Section: Technical Considerationsmentioning
confidence: 99%
“…This strategy can be combined with single-vector systems validated to express multiple gRNAs driven by polymerase-III promoters (Sakuma et al, 2014; Tsai et al, 2014), which may be useful to increase the effectiveness and flexibility of the gRNAs. Another noteworthy variation is to express gRNAs using polymerase-II promoters, a system that has proven highly efficient and adjustable for inducible expression (Nissim et al, 2014; Yoshioka et al, 2015). …”
Section: Technical Considerationsmentioning
confidence: 99%
“…These small nuclear RNA promoters are constitutively transcribed by RNA polymerase III (Pol III) and require a specific 5′ nucleotide to initiate transcription (5′-Guanine for U6 or 5′-Adenine for U3) (Jiang et al, 2013; Li et al, 2013; Nekrasov et al, 2013; Shan et al, 2013; Lowder et al, 2015). U6 and U3 promoters work well to express gRNAs in plants but they are not ideal for certain gene targeting applications due to lack of spatiotemporal control and the requirement of extra nucleotide restrictions on 5′ ends of target sequences or mismatch nucleotide additions on gRNA sequences (Gao and Zhao, 2014; Xie et al, 2015; Yoshioka et al, 2015; Tang et al, 2016). …”
Section: Diversified Expression Of Crispr System Componentsmentioning
confidence: 99%
“…An earlier study utilized this expression strategy for genome editing in wheat cells but obtained low Cas9 mutagenesis activity, presumably due to low activity of unprocessed Pol II expressed gRNAs (Upadhyay et al, 2013). Proper processing of Pol II expressed primary RNA for mature gRNAs has been demonstrated by utilizing the hammerhead and HDV ribozyme RNA self-cleavage system in yeast (Gao and Zhao, 2014), Arabidopsis (Gao, Y. et al, 2015), and mammalian cells (Yoshioka et al, 2015) (Figure 1B, top panel). Alternatively, the Pol II expressed gRNA containing primary RNA can be processed by the Csy4 RNA cleavage system as demonstrated in mammalian cells (Nissim et al, 2014) (Figure 1B, bottom panel).…”
Section: Pol Ii::cas9 and Pol Ii::grna—dual Pol II Promoter Systemsmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, multiple gRNAs can be produced from a single promoter so that each gRNA can have similar concentrations. Indeed, it has been reported that multiple gRNAs are successfully produced from RNA Pol II promoters using the ribozyme strategy in rice and in animal cells (Yoshioka et al, 2015; Tang et al, 2016). Furthermore, CRISPR-Cpf1 DNA-editing in rice has been successfully performed by utilizing gRNA produced from our RGR system, probably because our RGR system produces gRNA molecules with precise ends (Tang et al, 2017).…”
mentioning
confidence: 99%